SCHEDULE: T. Rowe Price Discloses 2.7% Stake in Novanta Inc.
Beneficial Ownership Disclosure
T. Rowe Price Associates, Inc. has filed an Amendment No. 2 to Schedule 13G, reporting a 2.7% beneficial ownership stake in Novanta Inc.
Summary
- T. Rowe Price Associates, Inc. filed an Amendment No. 2 to Schedule 13G regarding its holdings in Novanta Inc.
- The filing reports beneficial ownership of 972,533 shares of Novanta Inc. common stock.
- This represents 2.7% of the class of Novanta Inc.'s common stock.
- T. Rowe Price Associates, Inc. holds sole voting power over 947,621 shares and sole dispositive power over 972,429 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Novanta Inc.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing disclosing beneficial ownership, which is neutral in sentiment.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding institutional ownership in Novanta Inc.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires filing of this statement |
| 11/14/2025 | Signature date of the filing |
Keywords
Novanta Inc., T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.